PRO MEDICUS LIMITED — Director's Dealing 2015

Aug 26, 2015

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	18 December 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest	Ordinary fully paid shares in Pro Medicus
(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Limited held by the Akay SuperannuationFund of which the Director is a Trustee and
	Member
Date of change	26 August 2015
No. of securities held prior to change	30,067,500 ordinary shares consisting off:-
	29,700,000 ordinary shares held
	under Anthony Barry HALL
	367,500 ordinary shares held under
	Akay Superannuation Fund
Class	Ordinary shares
Number acquired	Off market transfer of 500,000 from Anthony
	Barry HALL to Akay Superannuation Fund
Number disposed	Nil
Value/Consideration	$1.91 cents per share
Note: If consideration is non-cash, provide details and estimated valuation

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	30,067,500 ordinary shares consisting off:-29,200,000 ordinary shares heldunder Anthony Barry HALL867,500 ordinary shares held underAkay Superannuation Fund
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Off market transfer

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

For and on behalf of Pro Medicus Limited

==> picture [133 x 63] intentionally omitted <==

Clayton Hatch Company Secretary 27 August 2015

• See chapter 19 for defined terms.

Appendix 3Y Page 3